Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraperitoneal Insulin Administration as Alternative for Intensive Subcutaneous Insulin Therapy in Patients With Type 1 Diabetes Mellitus.

NCT01621308 is registered in ClinicalTrials.gov with Medical Research Foundation, The Netherlands as lead sponsor.

NCT NCT01621308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01621308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraperitoneal Insulin Administration as Alternative for Intensive Subcutaneous Insulin Therapy in Patients With Type 1 Diabetes Mellitus.
Lead sponsor
Medical Research Foundation, The Netherlands
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
March 31, 2014
Enrollment
190 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus